Retinoids: novel immunomodulators and tumour-suppressive agents?

Print
Published on Friday, 23 January 2015

Abstract

Retinoids play important roles in the transcriptional activity of normal, degenerative and tumour cells.

Retinoid analogues may be promising therapeutic agents for the treatment of immune disorders as different as type I diabetes and systemic lupus erythematosus.

In addition, the use of retinoids in cancer treatment has progressed significantly in the last two decades; thus, numerous retinoid compounds have been synthesized and tested.

In this paper, the actual or potential use of retinoids as immunomodulators or tumour-suppressive agents is discussed.

 

 

About this publication.

 

See also:

- All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives);

- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy.